CGMBF(CGMBF)
CGMBF
No analyst ratings available
No analyst price targets available for CGMBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $143.96B | $148.84B | $154.34B |
| Low | $143.27B | $147.42B | $153.60B |
| High | $145.42B | $151.85B | $155.91B |
| EBITDA Avg | $21.21B | $21.93B | $22.74B |
| Low | $21.11B | $21.72B | $22.63B |
| High | $21.43B | $22.37B | $22.97B |
| EBIT Avg | $17.21B | $17.79B | $18.45B |
| Low | $17.12B | $17.62B | $18.36B |
| High | $17.38B | $18.15B | $18.63B |
| Net Income Avg | $29.91B | $31.20B | $31.75B |
| Low | $29.72B | $31.00B | $31.55B |
| High | $30.31B | $31.61B | $32.17B |
| EPS Avg | $0.65 | $0.68 | $0.69 |
| Low | $0.65 | $0.68 | $0.69 |
| High | $0.66 | $0.69 | $0.70 |
| Analysts (Rev / EPS) | 3 / 1 | 4 / 1 | 2 / 1 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|
| Revenue Avg | $62.37B | $61.66B | $60.95B | $60.25B | $59.56B |
| Low | $62.37B | $61.66B | $60.95B | $60.25B | $59.56B |
| High | $62.37B | $61.66B | $60.95B | $60.25B | $59.56B |
| EBITDA Avg | $9.19B | $9.08B | $8.98B | $8.88B | $8.77B |
| Low | $9.19B | $9.08B | $8.98B | $8.88B | $8.77B |
| High | $9.19B | $9.08B | $8.98B | $8.88B | $8.77B |
| EBIT Avg | $7.45B | $7.37B | $7.28B | $7.20B | $7.12B |
| Low | $7.45B | $7.37B | $7.28B | $7.20B | $7.12B |
| High | $7.45B | $7.37B | $7.28B | $7.20B | $7.12B |
| Net Income Avg | $11.34B | $23.00B | $13.10B | $24.45B | $13.97B |
| Low | $11.34B | $23.00B | $13.10B | $24.45B | $13.97B |
| High | $11.34B | $23.00B | $13.10B | $24.45B | $13.97B |
| EPS Avg | $0.26 | $0.52 | $0.30 | $0.55 | $0.32 |
| Low | $0.26 | $0.52 | $0.30 | $0.55 | $0.32 |
| High | $0.26 | $0.52 | $0.30 | $0.55 | $0.32 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |